Molecular Residual Disease and Efficacy of Adjuvant Chemotherapy in Patients With Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
Nat. Med. 2023 Jan 01;29(1)127-134, D Kotani, E Oki, Y Nakamura, H Yukami, S Mishima, H Bando, H Shirasu, K Yamazaki, J Watanabe, M Kotaka, K Hirata, N Akazawa, K Kataoka, S Sharma, VN Aushev, A Aleshin, T Misumi, H Taniguchi, I Takemasa, T Kato, M Mori, T YoshinoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.